{"id":40825,"date":"2020-10-14T10:03:38","date_gmt":"2020-10-14T04:33:38","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=40825"},"modified":"2020-10-14T10:03:38","modified_gmt":"2020-10-14T04:33:38","slug":"mexiletine-class-ib-id","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/","title":{"rendered":"Mexiletine &#8211; Class Ib (&#038; Id?)"},"content":{"rendered":"<h2><span style=\"color: #008000;\">Mexiletine &#8211; Class Ib (&amp; Id?)<\/span><\/h2>\n<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/NbQBcIdEkCU\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe><\/p>\n<p>Mexiletine is a Class Ib drug. But it has additional effect on late sodium current (I<sub>NaL<\/sub>), which qualifies for Id inclusion, though it has not been included in that group in the Modernized Classification of Cardiac Antiarrhythmic Drugs [1]. By virtue of that effect, it has been used successfully in the treatment of Long QT syndrome 3 (LQT3) [2]. In addition to shortening QTc, it has been shown to reduce life threatening arrhythmic events in LQT3 patients. It has also been found useful in Timothy syndrome, which is long QT syndrome type 8 (LQT8) [3]. In the case reported, mexiletine shortened QTc, abolished 2:1 AV block and T wave alternans. In a mouse model it was shown to be due to inhibition of late sodium current (I<sub>NaL<\/sub>).<\/p>\n<p>Intravenous preparation used to be available earlier. Currently only oral preparation is available. It has a half life of 10-14 hours, hence 8th hourly or twice daily dosage is preferred [4]. It has a role in the treatment of ventricular ectopics, ventricular tachycardia and prevention of ventricular fibrillation.<\/p>\n<p><strong><span style=\"color: #0000ff;\">References<\/span><\/strong><\/p>\n<ol>\n<li>Ming Lei, Lin Wu, Derek A Terrar, Christopher L-H Huang. <a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.118.035455\">Modernized Classification of Cardiac Antiarrhythmic Drugs<\/a>. Circulation. 2018 Oct 23;138(17):1879-1896.<\/li>\n<li>Andrea Mazzanti, Riccardo Maragna, Alessandro Faragli, Nicola Monteforte, Raffaella Bloise, Mirella Memmi, Valeria Novelli, Paola Baiardi, Vincenzo Bagnardi, Susan P Etheridge, Carlo Napolitano, Silvia G Priori. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26940925\/\">Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3<\/a>. J Am Coll Cardiol. 2016 Mar 8;67(9):1053-1058.<\/li>\n<li>Yuanfeng Gao, Xiaolin Xue, Dayi Hu, Wenling Liu, Yue Yuan, Hongmei Sun, Lei Li, Katherine W Timothy, Li Zhang, Cuilan Li, Gan-Xin Yan. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23580742\/\">Inhibition of late sodium current by mexiletine: a novel pharmotherapeutical approach in timothy syndrome<\/a>. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):614-22.<\/li>\n<li>Sana M Al-Khatib, William G Stevenson, Michael J Ackerman, William J Bryant, David J Callans, Anne B Curtis, Barbara J Deal, Timm Dickfeld, Michael E Field, Gregg C Fonarow, Anne M Gillis, Christopher B Granger, Stephen C Hammill, Mark A Hlatky, Jos\u00e9 A Joglar, G Neal Kay, Daniel D Matlock, Robert J Myerburg, Richard L Page. 2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Mexiletine &#8211; Class Ib (&amp; Id?) Mexiletine is a Class Ib drug. But it has additional effect on late sodium current (INaL), which qualifies for Id inclusion, though it has not been included in that group in the Modernized Classification of Cardiac Antiarrhythmic Drugs [1]. By virtue of that effect, it has been used successfully [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":40834,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[6],"tags":[2052,2208,2239,2241,3935],"class_list":["post-40825","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ecg-electrophysiology","tag-late-sodium-current","tag-long-qt-syndrome-3","tag-lqt3","tag-lqt8","tag-timothy-syndrome"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mexiletine - Class Ib (&amp; Id?) - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mexiletine - Class Ib (&amp; Id?) - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Mexiletine &#8211; Class Ib (&amp; Id?) Mexiletine is a Class Ib drug. But it has additional effect on late sodium current (INaL), which qualifies for Id inclusion, though it has not been included in that group in the Modernized Classification of Cardiac Antiarrhythmic Drugs [1]. By virtue of that effect, it has been used successfully [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-14T04:33:38+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Mexiletine &#8211; Class Ib (&#038; Id?)\",\"datePublished\":\"2020-10-14T04:33:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/\"},\"wordCount\":390,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"late sodium current\",\"Long QT syndrome 3\",\"LQT3\",\"LQT8\",\"Timothy syndrome\"],\"articleSection\":[\"ECG \\\/ Electrophysiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/\",\"name\":\"Mexiletine - Class Ib (& Id?) - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-10-14T04:33:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/mexiletine-class-ib-id\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mexiletine &#8211; Class Ib (&#038; Id?)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mexiletine - Class Ib (& Id?) - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/","og_locale":"en_US","og_type":"article","og_title":"Mexiletine - Class Ib (& Id?) - All About Cardiovascular System and Disorders","og_description":"Mexiletine &#8211; Class Ib (&amp; Id?) Mexiletine is a Class Ib drug. But it has additional effect on late sodium current (INaL), which qualifies for Id inclusion, though it has not been included in that group in the Modernized Classification of Cardiac Antiarrhythmic Drugs [1]. By virtue of that effect, it has been used successfully [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2020-10-14T04:33:38+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Mexiletine &#8211; Class Ib (&#038; Id?)","datePublished":"2020-10-14T04:33:38+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/"},"wordCount":390,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#primaryimage"},"thumbnailUrl":"","keywords":["late sodium current","Long QT syndrome 3","LQT3","LQT8","Timothy syndrome"],"articleSection":["ECG \/ Electrophysiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/","url":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/","name":"Mexiletine - Class Ib (& Id?) - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-10-14T04:33:38+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/mexiletine-class-ib-id\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Mexiletine &#8211; Class Ib (&#038; Id?)"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/40825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=40825"}],"version-history":[{"count":0,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/40825\/revisions"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=40825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=40825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=40825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}